With a robust background in private equity, the fund manager has successfully executed over 30 deals across technology and healthcare sectors, primarily in the Asia-Pacific region. Leveraging a data-driven investment approach, they have achieved notable exits, including a significant acquisition in the biotech space. Their strategic style emphasizes operator-first principles, ensuring value creation at every stage of the investment lifecycle. This combination of expertise and regional focus positions them as a formidable player in the competitive investment landscape.